---
title: "ESR2"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "# Information about Gene ESR2"
tags: ['GeneESR2', 'EstrogenReceptorBeta', 'Pathology', 'Function', 'Diseases', 'Treatment', 'DrugResponse', 'RelatedPapers']
---

# Information about Gene ESR2

## Genetic Position, Pathology, and Function
ESR2, also known as Estrogen Receptor Beta (ERβ), is a protein-coding gene located on chromosome 14q23.2. The gene is associated with numerous pathologies such as cancer, obesity, osteoporosis, and cardiovascular disease. ESR2 is a member of the nuclear hormone receptor family, and its main function is regulating gene expression in response to estrogen. It plays a crucial role in various physiological processes, such as the development and function of the female reproductive system, bone turnover, and brain function.

## Gene Function
The ESR2 gene is responsible for encoding the estrogen receptor beta protein, which acts as a transcription factor that regulates the expression of target genes involved in several biological processes such as cell proliferation and differentiation, apoptosis, and inflammation.

## External IDs for Gene and Genomic Location, Aliases
- HGNC: 3467
- NCBI Entrez: 2100
- Ensembl: ENSG00000141510
- OMIM: 601663
- UniProtKB/Swiss-Prot: P03372
- Aliases: ESRB, ER-BETA, ESTRB, NR3A2

## AA Mutation List and Mutation Type with dbSNP ID
There are many AA (amino acid) mutations associated with the ESR2 gene. Some of these mutations are:

Mutation Type | AA Position | Mutation | dbSNP ID
------- | ------- | ------- | -------
Missense | 10 | Valine (V) to Methionine (M) | rs4986938
Missense | 75 | Leucine (L) to Valine (V) | rs928554
Missense | 87 | Isoleucine (I) to Valine (V) | rs2228480
Missense | 311 | Threonine (T) to Alanine (A) | rs715461
Missense | 417 | Alanine (A) to Valine (V) | rs4986939

## Somatic SNVs/InDels with dbSNP ID
Some of the somatic SNVs (single nucleotide variations) or InDels (insertions or deletions) associated with the ESR2 gene are:

Type | Variant | dbSNP ID
------- | ------- | -------
SNV | T>C | rs55930754
SNV | G>A | rs371849475
InDel | CCGAGT>C | rs786205992
SNV | C>T | rs1031452508
SNV | A>G | rs148317172

## Related Diseases
The ESR2 gene plays a significant role in many pathological conditions such as:

- Breast cancer
- Prostate cancer
- Osteoporosis
- Cardiovascular disease
- Endometrial cancer
- Alzheimer's disease
- Parkinson's disease
- Multiple Sclerosis
- Depression

## Treatment and Prognosis
Several treatment options have been developed to target ESR2, particularly in breast cancer. These include endocrine therapies such as tamoxifen, selective estrogen receptor modulators (SERMs), and aromatase inhibitors.

Due to its role in multiple biological processes, ESR2 has been identified as a potential therapeutic target for various diseases. However, further research is needed to identify more effective drugs that work directly on ESR2.

## Drug Response
Several studies have shown that ESR2 expression levels can predict the response of cancer patients to certain drugs. For example, tamoxifen is only effective in patients with high ESR2 expression, and the loss of ESR2 expression predicts tamoxifen resistance.

## Related Papers

- *Lazennec G. Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis. Cancer Lett. 2006 Feb 8;231(2):151-7. doi: 10.1016/j.canlet.2005.02.042. Epub 2005 Jul 12. PMID: 16019251.*
- *Rajah TT, Du N, Drews NR, Cohn DV. (2003). Estrogen receptor-α and estrogen receptor-β regulate the human osteoblastic RANKL/OPG ratio via interleukin-17-producing T cells. Journal of Applied Physiology, 2003; 95(6): 2416-2424. doi: 10.1152/japplphysiol.00522.2003.*
- *Nelson AW, Groen AJ, Miller JL, Warren AY, Holmes KA, Tarulli GA, Tilley WD, Katzenellenbogen JA, Hawse JR, Gnanapragasam VJ, Carroll JS. Comprehensive assessment of estrogen receptor β antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity. Mol Cell Endocrinol. 2017 Feb 15;440:138-150. doi: 10.1016/j.mce.2016.12.030. Epub 2016 Dec 26. PMID: 28027956; PMCID: PMC5364293.*

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**